Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Classification of Epithelial Tissues: Overview01:22

Classification of Epithelial Tissues: Overview

13.9K
Epithelial tissues are classified according to the shape of the cells and the number of cell layers formed. Cell shapes can be squamous (flattened and thin), cuboidal (square-like, as wide as it is tall), or columnar (rectangular, taller than it is wide). Additionally, the nucleus shape helps identify the type of epithelial cells. Squamous cells have flattened disc-shaped nuclei, cuboidal cells have spherical nuclei, and columnar cells have elongated nuclei.
Based on the number of cell layers,...
13.9K
Classification of Epithelial Tissues: Stratified Epithelium01:29

Classification of Epithelial Tissues: Stratified Epithelium

9.4K
Stratified epithelium consists of several stacked layers of cells. They provide the durability to withstand constant physical and chemical attacks. Stratified epithelium is named after the shape of the most apical layer of cells. Stratified squamous epithelium is the most common type found in the human body. In this tissue, the apical cells are squamous, whereas the basal layer contains either columnar or cuboidal cells. The basal cells divide to form new daughter cells, which gradually become...
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.

Clinical cancer research : an official journal of the American Association for Cancer Research·2018
Same author

Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy.

Therapeutic advances in medical oncology·2018
Same author

Stress effects on FosB and interleukin-8 (<i>IL8</i>)-driven ovarian cancer growth and metastasis.

The Journal of biological chemistry·2018
Same author

Stress, inflammation, and eicosanoids: an emerging perspective.

Cancer metastasis reviews·2018
Same author

Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer.

Cancer·2018
Same author

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.

Drug delivery·2018

Related Experiment Video

Updated: Aug 25, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.7K

Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics.

Katelyn F Handley1,2,3, Travis T Sims1, Nicholas W Bateman4,5

  • 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston.

JAMA Network Open
|October 14, 2022
PubMed
Summary
This summary is machine-generated.

This study identified two distinct gross morphologic subtypes of high-grade serous ovarian cancer (HGSOC), revealing unique clinical and molecular differences. These findings may improve patient triage and guide tailored treatment strategies for ovarian cancer.

More Related Videos

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids
07:19

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids

Published on: January 6, 2023

4.6K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.1K

Related Experiment Videos

Last Updated: Aug 25, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.7K
Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids
07:19

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids

Published on: January 6, 2023

4.6K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.1K

Area of Science:

  • Oncology
  • Pathology
  • Genomics

Background:

  • High-grade serous ovarian cancer (HGSOC) lacks a systematic classification based on gross appearance despite observed clinical heterogeneity.
  • Histologic similarity in HGSOC masks significant variations in macroscopic tumor characteristics, impacting clinical management.

Purpose of the Study:

  • To develop and characterize a novel gross morphologic classification system for high-grade serous ovarian cancer.
  • To investigate the clinical and molecular distinctions between identified HGSOC morphologic subtypes.

Main Methods:

  • A cohort of 112 patients with suspected advanced-stage ovarian cancer underwent laparoscopic assessment for disease burden.
  • Tumor samples were histopathologically diagnosed as HGSOC and assigned a gross morphologic subtype by blinded researchers.
  • Integrated proteomic and transcriptomic analyses were performed on representative tumor samples.

Main Results:

  • Two distinct gross morphologic subtypes (Type I and Type II) of HGSOC were identified.
  • Type II tumors were associated with a more favorable Fagotti score, suggesting better surgical candidacy.
  • Molecular analysis revealed distinct pathway enrichments, including epithelial-mesenchymal transition in Type I and MYC signaling in Type II tumors.

Conclusions:

  • The study identified two novel, clinically relevant gross morphologic subtypes of HGSOC with unique molecular signatures.
  • This classification system may aid in patient triaging for surgery versus chemotherapy and inform the development of targeted therapies.
  • Understanding these morphologic subtypes offers potential for improved prognostication and personalized treatment strategies in ovarian cancer.